Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Leonardo Passos, Chaves"'
Autor:
Rupali Fuldeore, Leonardo Passos Chaves, Qi Feng, Nigel Rozario, David Nimke, Stephanie Braun
Publikováno v:
Future Oncology. 19:575-586
Aim: To describe treatment patterns, healthcare resource utilization and costs in HER2-negative gastric/gastroesophageal (G/GEJ) cancer in the USA. Methods: Retrospective IQVIA Adjudicated Closed Claims database analysis; patients with HER2-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::820b5335a546da0a84d97e18262d33a3
https://doi.org/10.2217/fon-2022-0977
https://doi.org/10.2217/fon-2022-0977
Autor:
Quoc-Dien, Trinh, Leonardo Passos, Chaves, Qi, Feng, Julia, Zhu, Rickard, Sandin, Thomas, Abbott
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:544-554
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57b0b1d0ecf47950b0aad4a6c99d446
https://doi.org/10.18553/jmcp.2022.28.5.544
https://doi.org/10.18553/jmcp.2022.28.5.544
Publikováno v:
Journal of Clinical Oncology. 41:511-511
511 Background: Treatment landscape in advanced/unresectable hepatocellular carcinoma (uHCC) has been rapidly changing. In June 2020, the first immuno-oncologic (I/O) + IV anti-angiogenic regimen for uHCC was approved as first line (1L) treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c22f1822394e507a2d49446410410ee5
https://doi.org/10.1200/jco.2023.41.4_suppl.511
https://doi.org/10.1200/jco.2023.41.4_suppl.511